Skyrizi's Rise
Learn more about Skyrizi™, the latest FDA-approved treatment for moderate-to-severe psoriasis.
Runtime - 1:09 minutes
Related Posts
BioPlus Specialty Pharmacy Earns #1 Independent Specialty Pharmacy Ranking in Physician Satisfaction Survey
BioPlus Specialty Pharmacy, a leading independent specialty pharmacy, is proud to announce a #1...
SKYRIZI™ Now Available From BioPlus for Moderate to Severe Plaque Psoriasis
BioPlus Specialty Pharmacy, one of the nation’s leading innovative specialty pharmacies, is...
Every Company Has a Founder’s Story: BioPlus Specialty Pharmacy’s Starts with Patient Care
The company that would eventually become BioPlus Specialty Pharmacy was founded more than three...
Skyrizi’s Rise
The U.S. Food and Drug Administration approved a new treatment option for psoriasis patients...
